IP Library Granted Patent US 8,512,254
Granted Patent B2
US 8,512,254 · App. 13/566,057 · Granted Aug 20, 2013

Optical sensor and method for detecting a patient condition

Inventor: William T. Donofrio (Andover, MN)
Assignee: Medtronic, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,512,254
App. No.
13/566,057
Granted
Aug 20, 2013
Kind
B2
Abstract

An implantable medical device for monitoring tissue perfusion that includes a light source emitting a light signal and a light detector receiving emitted light scattered by a volume of body tissue. The light detector emits a signal having an alternating current component corresponding to the pulsatility of blood flow in the body tissue volume. A processor receives the current signal and determines a patient condition in response to the alternating component of the current signal.

Claims (15)

1. An implantable medical device for monitoring blood flow pulsatility in a volume of body tissue in a patient, the device comprising:

at least two electrodes for sensing a cardiac electrical signal;

a light source for emitting a modulated light signal;

a filter for filtering the wavelengths of the modulated light signal scattered by the volume of body tissue;

a light detector for receiving the filtered modulated light signal and emitting a current signal having an alternating current component correlated to pulsatility of blood flow within the volume of body tissue;

a processor for receiving the cardiac electrical signal, detecting an arrhythmia in response to the cardiac electrical signal, receiving the light detector signal, determining a pulsatility metric in response to the alternating current component of the light detector signal, comparing the pulsatility metric to a heart rate determined from the cardiac electrical signal, confirming the arrhythmia in response to the comparison, and detecting T-wave oversensing in response to the cardiac electrical signal being greater than the pulsatility metric, wherein the pulsatility metric is a frequency of the alternating current component and; and

a therapy control module coupled to the processor and delivering an anti-arrhythmia therapy in response to the arrhythmia confirmation.

2. The device of claim 1 , wherein the processor is further configured to detect T-wave undersensing in response to the pulsatility metric being greater than the cardiac electrical signal.

3. The device of claim 1 , wherein the processor confirms the arrhythmia in response to the pulsatility metric being approximately equal to the cardiac electrical signal.

4. The device of claim 1 , further comprising a signal modulator modulating the emitted light signal wherein the processor demodulates light detector signal.

5. The device of claim 4 wherein the emitted light signal is modulated at a carrier frequency of approximately 100 to 10,000 Hz.

6. The device of claim 1 , wherein the light detector is a photo darlington device.

7. The device of claim 1 , wherein the processor determines one of a frequency of the alternating current component and a peak-to-peak amplitude difference of the alternating current component.

8. The device of claim 7 wherein the processor determines a heart rate from the cardiac electrical signals and compares the determined heart rate to the frequency of the alternating current component.

9. The device of claim 1 , wherein the processor further determines the presence of a motion artifact in the light detector signal.

Continuity (2)
Continuation 11963045 · Dec 21, 2007
Related Publication 20120303081A1 · Nov 29, 2012